Efficacy and Safety of Upadacitinib in Patients from China, Brazil, and South Korea with Rheumatoid Arthritis Who Have Had Inadequate Response to Conventional Synthetic Disease-modifying Antirheumatic Drugs-MedSci.cn

Efficacy and Safety of Upadacitinib in Patients from China, Brazil, and South Korea with Rheumatoid Arthritis Who Have Had Inadequate Response to Conventional Synthetic Disease-modifying Antirheumatic Drugs

Zeng, XF; Zhao, DB; Radominski, S; Keiserman, M; Lee, CK; Meerwein, S; Enejosa, J; Sui, YX; Mohamed, ME; Park, W